Guideline for the Prescribing of Novel Oral Anticoagulants (NOACs): Dabigatran (Pradaxa ), Rivaroxaban (Xarelto ), Apixaban (Eliquis ) - PDF Free Download
Bridging the Gap: How to Transition from the NOACs to Warfarin - PDF Free Download
Xarelto® - Responsible Use
How to switch from rivaroxaban to LMWH? | Download Scientific Diagram
How to switch from rivaroxaban to LMWH? | Download Scientific Diagram
Transition of Anticoagulants 2016
Treatment Considerations | XARELTO® (rivaroxaban) HCP
Recommendations for Switching to and From Rivaroxaban 9 | Download Table
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial - The Lancet
RBCP - Cost comparison between enoxaparin and new oral anticoagulants dabigatran and rivaroxaban in venous thromboembolism prophylaxis
Cureus | Clinical Outcomes and Costs of Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Inpatients: A Cross-Sectional Study
Oral anticoagulants in the management of venous thromboembolism | Nature Reviews Cardiology
New Oral Anticoagulants: A Review - ppt video online download
Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians With Atrial Fibrillation - ScienceDirect
Anticoagulants | Health Navigator NZ
Guidance on converting between anticoagulants
Transition of Anticoagulants 2014
Updated Guidelines on Outpatient Anticoagulation | AAFP
Cureus | Current Trends in the Duration of Anticoagulant Therapy for Venous Thromboembolism: A Systematic Review
Rivaroxaban: a fully-subsidised oral anticoagulant
Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges | Journal of the American Heart Association
Pharmacokinetic and pharmacodynamic evaluation of rivaroxaban: considerations for the treatment of venous thromboembolism | Thrombosis Journal | Full Text
Safety Profile - DVT & PE Initial Treatment | XARELTO® (rivaroxaban) HCP
Antithrombotic Management of Venous Thromboembolism: JACC Focus Seminar - ScienceDirect
